In yesterday’s Wall Street session, Adma Biologics Inc (NASDAQ:ADMA) shares traded at $17.29, down -5.93% from the previous session.
ADMA stock price is now 19.59% away from the 50-day moving average and 105.62% away from the 200-day moving average. The market capitalization of the company currently stands at $4.03B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On October 13, 2022, Mizuho recently initiated its ‘Buy’ rating on the stock quoting a target price of $5, while ‘Raymond James’ rates the stock as ‘Strong Buy’
In other news, Guiheen Lawrence P., Director bought 9,000 shares of the company’s stock on Sep 09 ’24. The stock was bought for $146,340 at an average price of $16.26. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 30 ’24, COO and SVP, Compliance Kestenberg-Messina Kaitlin M. sold 24,150 shares of the business’s stock. A total of $408,050 was realized by selling the stock at an average price of $16.90. This leaves the insider owning 449,088 shares of the company worth $7.76 million. A total of 3.41% of the company’s stock is owned by insiders.
During the past 12 months, Adma Biologics Inc has had a low of $3.06 and a high of $19.34. As of last week, the company has a debt-to-equity ratio of 0.75, a current ratio of 6.87, and a quick ratio of 2.80. The fifty day moving average price for ADMA is $14.5799 and a two-hundred day moving average price translates $8.475525 for the stock.
The latest earnings results from Adma Biologics Inc (NASDAQ: ADMA) was released for 2024-06-30. The net profit margin was 10.53% and return on equity was 20.77% for ADMA. The company reported revenue of $107.19 million for the quarter, compared to $60.12 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 78.29 percent.
